Related Experiment Video

Updated: Jun 10, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Two cases of recurrent stroke in treated giant cell arteritis: diagnostic and therapeutic dilemmas

Alasdair J Fitzgerald1, James W Ironside, David M Summers

  • 1Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, Scotland. alasdair.fitzgerald@nhs.net

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|July 28, 2010
PubMed

Insights

Giant cell arteritis (GCA) patients face stroke risks from various causes. Even with treatment, persistent inflammation can lead to strokes, highlighting diagnostic challenges.

Area of Science:

  • Neurology
  • Rheumatology
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is associated with an increased risk of stroke.
  • The precise cause of stroke in GCA patients remains unclear, complicating treatment decisions.
  • Potential causes include atherosclerosis, ongoing arterial inflammation, or corticosteroid side effects.

Observation:

  • Two GCA patients experienced recurrent strokes in different arterial territories after starting corticosteroid therapy.
  • Cranial symptoms resolved and inflammatory markers normalized in these patients.
  • Further investigation indicated persistent arteritis as the cause of the strokes.

Findings:

  • Laboratory tests and imaging may not accurately reflect the cause of stroke in GCA patients.
  • Persistent arteritis can cause strokes even when clinical and laboratory markers of inflammation appear controlled.
  • Current diagnostic methods have limitations in assessing stroke etiology in GCA.

Implications:

  • There is a critical need for improved methods to monitor GCA activity.
  • Developing effective strategies to determine the optimal treatment for stroke prevention in GCA is essential.
  • Further research is required to elucidate the pathophysiology of stroke in GCA and refine therapeutic approaches.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...